Mylan Hungary KFT Mylan Pharmaceutical Import Profile — Hungary (DGFT 2022–2026)

Name: Mylan Hungary KFT Mylan Pharmaceutical Import Records from India — 2 Products, $200.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Mylan Hungary KFT Mylan — Pharmaceutical Importer Profile (2026) | 2 Products, $200.0K Trade | TransData Nexus

Mylan Hungary KFT Mylan

Pharmaceutical Importer · Hungary · Antimalarial & Antiparasitic Focus · $200.0K Total Trade · DGFT Verified

Mylan Hungary KFT Mylan is a pharmaceutical importer based in Hungary with a total trade value of $200.0K across 2 products in 1 therapeutic categories. Based on 4 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Mylan Hungary KFT Mylan sources from 2 verified Indian suppliers, with Mylan Laboratories Limited accounting for 98.5% of imports.

Mylan Hungary KFT Mylan — Import Portfolio & Supplier Network

Mylan Hungary KFT Mylan import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Mylan Hungary KFT Mylan?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mylan Laboratories Limited	$6.0M	156	98.5%
Unichem Laboratories Limited	$94.4K	2	1.5%

Mylan Hungary KFT Mylan sources from 2 verified Indian suppliers across .

What Formulations Does Mylan Hungary KFT Mylan Import?

Formulation	Value	Ships
Duloxetine hard Gastro-Resistant capsules 60 MG packs 4000s	$300.0K	6
Ibuprofen tablets 400 MG packs	$226.3K	5
Harmless medicines, propafenone hydrochloride film coated tablets 150 MG	$150.0K	3
Harmless medicines, pantoprazole sodiumdelayed-release tablets 40 MG	$150.0K	3
Pravastatin sodium tablets 40 MG packs 2500s	$150.0K	3
Harmless medicines zolpidem tartrate 10MG	$141.7K	8
Ibuprofen tablets 600 MG packs : 6000's	$125.5K	3
Harmless medicines:- ibuprofen tablets 400 MG 3,096,840.000	$114.7K	3
Propafenone hydrochloride film coated tablets 150 MG packs 20000s	$100.0K	2
Pantoprazole sodium delayed-release tablets 40 MG packs 22000s	$100.0K	2
Amisulpride tablets 100 MG packs 22000s	$100.0K	2
Amisulpride tablets 200 MG packs 11000s	$100.0K	2
Amisulpride tablets 400 MG packs 5600s	$100.0K	2
Valsartan and hydrochlorothiazide tablets 160 MG/25 MG packs: 9000's	$100.0K	2
Ibuprofen lysine tablets 684MG packs 4000s	$100.0K	2

Mylan Hungary KFT Mylan imports 109 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Atovaquone	Antimalarial & Antiparasitic	$100.0K	2	0.0%	8
2	Proguanil	Antimalarial & Antiparasitic	$100.0K	2	0.0%	2

Mylan Hungary KFT Mylan imports 2 pharmaceutical products across 1 categories into Hungary totaling $200.0K.

Mylan Hungary KFT Mylan — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Mylan Hungary Kft., headquartered at Mylan utca 1, Komárom, Hungary, operates as a pharmaceutical importer and buyer specializing in finished pharmaceutical formulations. Established on June 14, 2010, the company is a subsidiary of Viatris, a global healthcare entity formed in November 2020 through the merger of Mylan N.V. and Pfizer's off-patent medicine division, Upjohn. Mylan Hungary Kft. plays a pivotal role in Hungary's pharmaceutical distribution network, focusing on the importation and distribution of generic and specialty medicines across various therapeutic areas. The company's strategic emphasis is on enhancing access to medicines, expanding its portfolio, and ensuring a reliable pharmaceutical supply within Hungary.

2Distribution Network

While specific details regarding Mylan Hungary Kft.'s warehouse locations and logistics capabilities are not publicly disclosed, the company's operations are strategically designed to ensure efficient distribution across Hungary. As part of Viatris, Mylan Hungary Kft. benefits from an extensive global distribution network, facilitating the timely delivery of pharmaceutical products to healthcare providers, pharmacies, and patients throughout Hungary. This network is supported by Viatris's manufacturing, research and development, and distribution facilities, which are strategically located to meet customer needs effectively.

3Industry Role

Mylan Hungary Kft. functions as a pharmaceutical importer and buyer within Hungary's supply chain, focusing on the importation and distribution of finished pharmaceutical formulations. The company's operations are integral to the Hungarian pharmaceutical market, ensuring the availability of a diverse range of generic and specialty medicines. By leveraging Viatris's global resources and expertise, Mylan Hungary Kft. contributes significantly to the accessibility and reliability of pharmaceutical products in Hungary.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Mylan Hungary KFT Mylan

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Mylan Hungary Kft.'s sourcing strategy exhibits a high degree of concentration, with a total import value of $200,000 USD from India across four shipments, importing two products within a single therapeutic category—Antimalarial & Antiparasitic. The top two products, Atovaquone and Proguanil, each account for $100,000 USD, indicating a balanced investment in these specific formulations. This sourcing pattern suggests a strategic focus on these products, potentially to leverage cost efficiencies and supply chain synergies. However, the limited diversification in both product range and supplier base may expose the company to risks associated with supply chain disruptions or regulatory changes affecting these specific products. The relationship with the two Indian suppliers—Mylan Laboratories Limited and Unichem Laboratories Limited—appears stable, with Mylan Laboratories Limited accounting for 98.5% of the shipments. This dominance may reflect a strategic partnership or favorable contractual terms, but it also underscores the importance of maintaining a robust and reliable relationship with this primary supplier to mitigate potential supply chain vulnerabilities.

2Supply Chain Resilience

Mylan Hungary Kft.'s supply chain resilience is closely tied to its sourcing strategy from India, particularly from Mylan Laboratories Limited, which constitutes 98.5% of the company's imports. The limited number of suppliers and the concentration on a single therapeutic category may pose challenges in terms of supply chain flexibility and responsiveness to market changes. The company's reliance on a single supplier for the majority of its imports necessitates a strong and dependable relationship to ensure consistent product quality and timely delivery. To enhance supply chain resilience, Mylan Hungary Kft. could consider diversifying its supplier base and expanding its product portfolio, thereby reducing dependency on a single source and mitigating potential risks associated with supply chain disruptions.

Importing Pharmaceuticals into Hungary — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Hungary

1Regulatory Authority & Framework

In Hungary, the National Institute of Pharmacy and Nutrition (OGYÉI) serves as the primary regulatory authority overseeing pharmaceutical imports, marketing authorizations, and the overall regulation of medicinal products. The key legislation governing pharmaceutical imports includes the Act on Medicinal Products and the Act on the Distribution of Medicinal Products, which establish the legal framework for the importation, distribution, and sale of pharmaceutical products in Hungary. For Indian generics to be marketed in Hungary, they must undergo a centralized marketing authorization process through the European Medicines Agency (EMA), which evaluates the safety, efficacy, and quality of medicinal products. Once approved by the EMA, the product can be marketed across all EU member states, including Hungary.

2Import Licensing & GMP

Import licensing in Hungary requires that pharmaceutical products comply with Good Manufacturing Practice (GMP) standards recognized by the European Union. Indian manufacturers seeking to export to Hungary must ensure that their facilities are certified by EU-recognized authorities, such as the European Medicines Agency (EMA) or the World Health Organization (WHO). This certification ensures that the manufacturing processes meet the stringent quality standards required for the European market. Additionally, Indian exporters must obtain a wholesale distribution authorization from the Hungarian authorities, which permits the importation and distribution of pharmaceutical products within Hungary.

Mylan Hungary KFT Mylan — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Mylan Hungary Kft.'s focus on importing antimalarial and antiparasitic formulations, specifically Atovaquone and Proguanil, indicates a strategic emphasis on addressing specific therapeutic needs within Hungary. The market demand for these products is likely driven by the prevalence of malaria and other parasitic infections in the region, necessitating effective treatment options. By concentrating on these products, Mylan Hungary Kft. aims to provide targeted solutions that meet the healthcare needs of the Hungarian population, leveraging its expertise and resources to ensure the availability of high-quality medicines in this therapeutic area.

2Sourcing Profile

Mylan Hungary Kft.'s sourcing strategy is centered on importing generic formulations from India, particularly from Mylan Laboratories Limited. This approach allows the company to offer cost-effective alternatives to branded medications, enhancing accessibility for patients. The focus on specific formulations, such as Atovaquone and Proguanil, suggests a strategic alignment with market needs and therapeutic demands. India's well-established pharmaceutical manufacturing sector, known for its adherence to international quality standards, makes it a reliable source for these products.

3Market Positioning

Seller's Guide — How to Become a Supplier to Mylan Hungary KFT Mylan

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Mylan Hungary Kft., especially if they can offer complementary products or formulations that align with the company's strategic focus on antimalarial and antiparasitic treatments. Expanding the supplier base could provide Mylan Hungary Kft. with access to a broader range of products, enhancing its portfolio and meeting diverse patient needs. For Indian exporters, this collaboration presents an opportunity to enter the Hungarian market, leveraging Mylan Hungary Kft.'s established distribution network and market presence.

2Requirements & Qualifications

Indian exporters seeking to supply Mylan Hungary Kft. must ensure that their manufacturing facilities are certified by EU-recognized authorities, such as the European Medicines Agency (EMA) or the World Health Organization (WHO), to meet GMP standards. Products must comply with Hungarian labeling requirements, including information in Hungarian and adherence to serialization mandates. Additionally, exporters must obtain the necessary import licenses and wholesale distribution authorizations from Hungarian regulatory authorities to facilitate the importation and distribution of their products within Hungary.

Frequently Asked Questions — Mylan Hungary KFT Mylan

What products does Mylan Hungary KFT Mylan import from India?

Mylan Hungary KFT Mylan imports 2 pharmaceutical products across 1 categories. Top imports: Atovaquone ($100.0K), Proguanil ($100.0K).

Who supplies pharmaceuticals to Mylan Hungary KFT Mylan from India?

Mylan Hungary KFT Mylan sources from 2 verified Indian suppliers. The primary supplier is Mylan Laboratories Limited (98.5% of imports, $6.0M).

What is Mylan Hungary KFT Mylan's total pharmaceutical import value?

Mylan Hungary KFT Mylan's total pharmaceutical import value from India is $200.0K, based on 4 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Mylan Hungary KFT Mylan focus on?

Mylan Hungary KFT Mylan imports across 1 categories. The largest: Antimalarial & Antiparasitic (100.0%).

Get Full Mylan Hungary KFT Mylan Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.